Docetaxel compared with sequential methotrexate and 5-fluorouracil in patients with advanced breast cancer after anthracycline failure: a randomised phase III study with crossover on progression by the Scandinavian Breast Group

J Sjöström, Carl Blomqvist, Henning T. Mouridsen, +10

European Journal of Cancer

Breast OncologyOncologyAnthracycline FailureSequential MethotrexateBreast Cancer +5

Prognostic value of quality of life scores for time to progression (TTP) and overall survival time (OS) in advanced breast cancer

Minna‐Liisa Luoma, Liisa Hakamies‐Blomqvist, J Sjöström, +8

European Journal of Cancer

Quality Of LifeLife AssessmentOverall Survival TimeBreast OncologyLongevity +10

Cyclin A as a marker for prognosis and chemotherapy response in advanced breast cancer

J Sjöström, Rose‐Marie Amini, Kenneth Villman, +2

British Journal of Cancer

A multivariate analysis of tumour biological factors predicting response to cytotoxic treatment in advanced breast cancer

J Sjöström, Stanisław Krajewski, Kaarle Franssila, +5

British Journal of Cancer

Tumor BiologyAdvanced Breast CancerBreast OncologyMedicinePathology +8

Quality of life in patients with metastatic breast cancer receiving either docetaxel or sequential methotrexate and 5-fluorouracil. A multicentre randomised phase III trial by the Scandinavian Breast Group

Liisa Hakamies‐Blomqvist, Minna‐Liisa Luoma, J Sjöström, +9

European Journal of Cancer

Metastatic Breast CancerBreast OncologyMedicinePhase Iii TrialBreast Cancer +5

C-erbB-2 expression does not predict response to docetaxel or sequential methotrexate and 5-fluorouracil in advanced breast cancer

J Sjöström, Juhani Collan, Kristina von Boguslawski, +10

European Journal of Cancer

Tumor BiologyAdvanced Breast CancerSystems BiologyBreast OncologyC-erbb-2 Expression +10

Timing of quality of life (QoL) assessments as a source of error in oncological trials

Liisa Hakamies‐Blomqvist, Minna‐Liisa Luoma, J Sjöström, +8

Journal of Advanced Nursing

Serum tumour markers CA 15-3, TPA, TPS, hCG β and TATI in the monitoring of chemotherapy response in metastatic breast cancer

J Sjöström, Henrik Alfthan, Heikki Joensuu, +3

Scandinavian Journal of Clinical and Laboratory Investigation

Newly Diagnosed Latent Autoimmune Diabetes in Adults (LADA) is Associated with Low Level Glutamate Decarboxylase (GAD65) and IA-2 Autoantibodies

Dorota B. Schranz, Lynn M. Bekris, Mona Landin‐Olsson, +6

Hormone and Metabolic Research

Metabolic SyndromeLatent Autoimmune DiabetesAutoimmune DiseaseQuantitative AssayDiabetes Epidemiology +12

Tumour microvessel density as predictor of chemotherapy response in breast cancer patients

Olli Tynninen, J Sjöström, Kristina von Boguslawski, +8

British Journal of Cancer